Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review

Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

    • Business description – A detailed description of the company’s operations and business divisions.
    • Corporate strategy – Analyst’s summarization of the company’s business strategy.
    • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
    • Company history – Progression of key events associated with the company.
    • Major products and services – A list of major products, services and brands of the company.
    • Key competitors – A list of key competitors to the company.
    • Key employees – A list of the key executives of the company.
    • Executive biographies – A brief summary of the executives’ employment history.
    • Key operational heads – A list of personnel heading key departments/functions.
    • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
    • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
    • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
    Highlights

    Plus Therapeutics Inc (Plus Therapeutics) is a developmental stage pharmaceutical company which focuses on discovery, development, and manufacturing of complex and innovative treatments for patients with cancer and other life-threatening diseases. Its pipeline products include Doceplus, a patented albumin-stabilized Pegylated liposomal formulation of docetaxel and Doxoplus, a complex, injectable, generic Pegylated liposomal formulation of doxorubicin. The company uses its proprietary nanotechnology platform to reformulate and improve conventional chemotherapeutics to provide meaningful benefits to healthcare providers and patients. Plus is headquartered in Irvine, Texas the US.

    Plus Therapeutics Inc Key Recent Developments

    Nov 14,2019: Plus Therapeutics reports third quarter 2019 financial and business results
    Jul 16,2019: Cytori will become Plus Therapeutics
    May 14,2019: Cytori reports Q1 2019 business and financial results
    Apr 01,2019: Cytori reports fourth quarter and full year 2018 business and financial results
    Nov 14,2018: Cytori reports Q3 2018 business and financial results

    Key benefits of buying this profile include:

    You get detailed information about the company and its operations to identify potential customers and suppliers.
    The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

    Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
    The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
    Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
    Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
    Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company


    Section 1 - About the Company
    Plus Therapeutics Inc - Key Facts
    Plus Therapeutics Inc - Key Employees
    Plus Therapeutics Inc - Key Employee Biographies
    Plus Therapeutics Inc - Major Products and Services
    Plus Therapeutics Inc - History
    Plus Therapeutics Inc - Company Statement
    Plus Therapeutics Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Section 2 – Company Analysis
    Company Overview
    Plus Therapeutics Inc - Business Description
    R&D Overview
    Plus Therapeutics Inc - SWOT Analysis
    SWOT Analysis - Overview
    Plus Therapeutics Inc - Strengths
    Plus Therapeutics Inc - Weaknesses
    Plus Therapeutics Inc - Opportunities
    Plus Therapeutics Inc - Threats
    Plus Therapeutics Inc - Key Competitors
    Section 3 – Company Financial Ratios
    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts
    Section 4 – Company’s Lifesciences Financial Deals and Alliances
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Plus Therapeutics Inc, Recent Deals Summary
    Section 5 – Company’s Recent Developments
    Nov 14, 2019: Plus Therapeutics reports third quarter 2019 financial and business results
    Jul 16, 2019: Cytori will become Plus Therapeutics
    May 14, 2019: Cytori reports Q1 2019 business and financial results
    Apr 01, 2019: Cytori reports fourth quarter and full year 2018 business and financial results
    Nov 14, 2018: Cytori reports Q3 2018 business and financial results
    Aug 14, 2018: Cytori reports Q2 2018 business and financial results
    Aug 09, 2018: Cytori reports publication of interim pilot data for cell therapy in vocal fold scarring
    May 10, 2018: Cytori Reports Q1 2018 Business and Financial Results
    Mar 08, 2018: Cytori Reports Fourth Quarter and Full Year 2017 Business and Financial Results
    Section 6 – Appendix
    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer
    List of Tables
    Plus Therapeutics Inc, Key Facts
    Plus Therapeutics Inc, Key Employees
    Plus Therapeutics Inc, Key Employee Biographies
    Plus Therapeutics Inc, Major Products and Services
    Plus Therapeutics Inc, History
    Plus Therapeutics Inc, Other Locations
    Plus Therapeutics Inc, Subsidiaries
    Plus Therapeutics Inc, Key Competitors
    Plus Therapeutics Inc, Ratios based on current share price
    Plus Therapeutics Inc, Annual Ratios
    Plus Therapeutics Inc, Annual Ratios (Cont...1)
    Plus Therapeutics Inc, Interim Ratios
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
    Plus Therapeutics Inc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios
    List of Figures
    Plus Therapeutics Inc, Performance Chart (2014 - 2018)
    Plus Therapeutics Inc, Ratio Charts
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
    Plus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook